Writing

September 10, 2026

Turning red when you drink is not a cosmetic problem

Written by Lifecode Labs
Two friends at a dinner table with the same glass of wine, one with a face and neck flushed deep red and one unchanged

If your face goes red after one drink, you know the routine. The jokes, the photos you untag, the antacid before a party so nobody notices. Around 560 million people have this reaction, most of them in East Asia, and almost all of them treat it as something to hide.

It is not something to hide. It is the only time your body reports on your genes in real time, and the standard response is to switch the report off.

What the flush is

Your body breaks alcohol down in two steps. First it becomes acetaldehyde, a toxic compound. Then an enzyme called ALDH2 turns the acetaldehyde into something harmless. In most people the second step keeps pace with the first. If you carry the common ALDH2 variant, it runs 60 to 80 percent slower with one copy and around 90 percent slower with two.

Two steps, one bottleneck
A left-to-right flow diagram: a glass of alcohol, an arrow labelled ADH into a circle crowded with acetaldehyde particles, then a slow ALDH2 step with a gauge reading low that lets only a trickle through to a cleared droplet, with icons for a red face, a racing heart and a headache below the crowded circle

Acetaldehyde pools in your blood, your body releases histamine, and you get the red face, the racing heart, the headache and the nausea. About 36 percent of East Asians carry at least one copy, and the variant is almost absent everywhere else. None of this is about tolerance or practice.

Why it is not cosmetic

Acetaldehyde is a Group 1 carcinogen, the same category as tobacco smoke. People with a working enzyme clear it in minutes. Carriers sit in it for hours, and the tissue that takes the hit is the lining of the mouth, throat and oesophagus.

In a Korean study, men with one copy had nearly three times the rate of oesophageal cancer of men without it, and among heavy drinkers the risk runs far higher. East Asia has the highest oesophageal cancer rates in the world while drinking less than Europe, and this variant is a large part of why. One estimate found that about half of these cancers in Japanese men could be prevented if carriers who drink moderately or heavily became light drinkers.

Which brings us to the antacid. Famotidine and similar pills do reduce the redness, because they block the histamine. They do nothing to the acetaldehyde. The face calms down, the carcinogen stays, and the person drinks more because the thing telling them to stop has gone quiet. It is the one health warning people pay money to disable.

Why the flush alone is a bad test

You flush, so you carry it. Usually true, but the flush fails as a test in three ways.

It fades. After years of regular drinking many carriers find the redness milder and take it as their body adjusting. The enzyme has not changed. The signal has weakened for exactly the people drinking the most.

It has other causes. A different gene, ADH1B, speeds up the first step instead of slowing the second, and it also produces a flush, with a much smaller cancer risk because the acetaldehyde is still cleared. Rosacea, histamine in wine and some medications redden the face too. From the outside they all look the same.

And one copy is not two. People with two copies react so badly that most barely drink, and their cancer risk is low. People with one copy can drink, usually do, and are the group nearly all of the risk falls on.

The same red face, three different reasons
Three people flushing after a drink, with cutaways showing slow ALDH2, fast ADH1B, and rosacea, each labelled with a different level of risk

What your DNA adds

Your genome replaces a signal that fades, that other conditions can mimic and that a pill can switch off, with an answer that does none of those things.

It tells you which gene is behind your flush, which is the difference between a quirk and a risk. It tells you whether you carry one copy or two, which is the difference between someone who should watch their drinking and someone whose body has already decided. And it puts a number on something you have been carrying as a joke, so that “moderate drinking” stops being a poster and becomes your own calculation. For a carrier the safe amount is lower than the guidelines say, and that is worth knowing before the habit forms.

The same variant also means a lower risk of alcohol dependence, worse hangovers, and a weaker response to nitroglycerin, a common heart drug that relies on the same enzyme. All of it sits in one place, and you read it once.

What to do with it

Your drinking. One copy, set your limit below the standard advice, which was written for people who clear acetaldehyde. Two copies, your body already set the limit. Stop trying to keep up.

Your antacid. Stop taking it before you drink. The redness was doing its job. If you want to be at the party without flushing, the fix is a smaller glass, not a pill that hides what the glass is doing.

Your family. This is one gene, so your parents, siblings and children carry it in predictable ways. If you flush, the people who flush at your table share it, and it is worth a conversation.

Your future self. ALDH2 research is moving into heart disease and beyond. New findings are applied to your sequence as they land, without another swab.

This is information rather than a diagnosis. Difficulty controlling how much you drink, or flushing without alcohol, are reasons to see a doctor.

The same reading, everywhere else

The gene behind your flush is one of dozens that decide how your body handles what you put into it, from caffeine and your sleep to painkillers after surgery. Your face is the one place you can watch it work. The same reading covers the places you cannot.

Lifecode reads all 6.4 billion letters of it once, then re-reads them as the science improves, so what your sequence says about this today is the least it will ever tell you. That is why we built Lifecode.

Read your own genome.

Order your genome